Home    About Us    Medic-All    Bio B2B    Hot Topic     Expo     Login | Join Now          
Bio B2BACT Genomics 〉DNA Repair Gene Testing

DNA Repair Gene Testing

DNA Repair Gene Testing

Most powerful in PARP inhibitor evaluation. NGS panel design of 48 genes (BRCA1/2 only for ACTBRCA®) and provide medical report in 14 calendar days.

Request for Collaboration
Overview
ACTBRCA®/ACTBRCA® HRD : DNA Repair Gene Testing is used to examine the genetic mutations in cancer patients for their personalized treatment plan. It is a breakthrough product to support current clinical guideline.
Using next generation sequencing (NGS) to test 48 DNA Repair genes, ACTBRCA®/ACTBRCA® HRD provides opportunities to use PARP inhibitor for breast and ovarian cancers.
 
Features
  • Most powerful in PARP inhibitor evaluation
  • NGS panel design of 48 DNA repair genes
  • AI-powered bioinformatics analysis of cancer genetic mutations of SNV & Indel and LGR in cancer signaling pathways.
  • High-quality test result in CAP-certified lab
  • Fast turnaround time with 14 calendar days  
Specifications
  • Next Generation Sequencing : 48 DNA repair genes
  • NGS Sequencing Mean Depth:>500 X
  • Sample Types : FFPE (5-20 unstained sections : 10µm/slide and 1H&E stained slide : 5µm)                                                               *Cell block from pleural effusion, ascites or pericardial hydrops (≥1X106cells)
Application
For breast and ovarian cancer patients who are looking for new treatment options
 
Collaboration Options
  • Clinical Services : Provide cancer genomic profiling to enable personalized treatment plan.
  • Biomarker Discovery : We provide comprehensive cancer genomic profiling to facilitate biomarker discovery. Customized assay is available.
  • Patient Stratification : From next generation sequencing, IHC and PCR assay, we utilize various platforms to screen patients prospectively.
  • Consultation : Our team of industry veterans and in-house clinical database offer insights to ensure smooth clinical trial operations.
  • CDx Development : We offer companion diagnostic development on NGS-based or CHIP-based multiplex qPCR platforms.
People who like this also like
  • U-Motion II⁺™U-Motion II⁺™
  • Colloidal Au NanoparticlesColloidal Au Nanoparticles
  • UCP™ StemUCP™ Stem
  • Bipolar II™ SystemBipolar II™ System
  • CMA™ BaseplateCMA™ Baseplate
  • NanoQ Coenzyme Q10 ProductsNanoQ Coenzyme Q10 Products
  • Facial Dermal ImplantFacial Dermal Implant
  • ApoX Anti-virus sprayApoX Anti-virus spray
  • Pemetrexed Lyo Inj.Pemetrexed Lyo Inj.
  • PSA™ Revision KneePSA™ Revision Knee